Literature DB >> 23002383

Management of Cancer Related Distress in Patients with a Hematological Malignancy.

Tara A Albrecht1, Margaret Rosenzweig.   

Abstract

Patients with hematologic malignancies often require urgent, aggressive, and lengthy chemotherapy treatment. These treatment regimens, divided into cycles, result in extended, often isolating periods of hospitalization where any direct clinical benefit for the patient, such as remission or "no evidence of disease" is not immediately declared. Consequently, this population is at a high risk of experiencing severe levels of cancer related distress. Cancer related distress is a complex psychosocial phenomenon that has consequences for patients, their families as well as the healthcare staff. Thus the importance of prevention, early recognition, treatment and management is unquestionable. Nurses have an important role to help identify and manage the presence of cancer related distress in these patients, as well as their family's. Nurses should work proactively in close partnership with an interdisciplinary team to effectively provide the necessary support for patients experiencing or who are at risk for high levels of cancer related distress. This case study and subsequent discussion illustrates the symptom management needs and challenges related to cancer related distress in the patient with a hematologic malignancy. Current evidence-based practice guidelines for the assessment and management of cancer related distress will be presented.

Entities:  

Year:  2012        PMID: 23002383      PMCID: PMC3445415          DOI: 10.1097/NJH.0b013e318268d04e

Source DB:  PubMed          Journal:  J Hosp Palliat Nurs        ISSN: 1522-2179            Impact factor:   1.918


  16 in total

1.  Screening for distress in cancer patients: the NCCN rapid-screening measure.

Authors:  Benson M Hoffman; Michael A Zevon; Mary C D'Arrigo; Tracy B Cecchini
Journal:  Psychooncology       Date:  2004-11       Impact factor: 3.894

2.  Somatic symptoms of distress: an international primary care study.

Authors:  G Simon; R Gater; S Kisely; M Piccinelli
Journal:  Psychosom Med       Date:  1996 Sep-Oct       Impact factor: 4.312

Review 3.  Screening for cancer-related distress: Summary of evidence from tools to programmes.

Authors:  Pernille Envold Bidstrup; Christoffer Johansen; Alex J Mitchell
Journal:  Acta Oncol       Date:  2011-02       Impact factor: 4.089

Review 4.  Clinical practice guidelines for the management of psychosocial distress at the end of life.

Authors:  Mauricio Murillo; Jimmie C Holland
Journal:  Palliat Support Care       Date:  2004-03

5.  Qualitative findings on the experience of end-of-life care for hematological malignancies.

Authors:  Pam McGrath
Journal:  Am J Hosp Palliat Care       Date:  2002 Mar-Apr       Impact factor: 2.500

6.  Routine screening for psychological distress on an Australian inpatient haematology and oncology ward: impact on use of psychosocial services.

Authors:  Stuart J Lee; Lynda J Katona; Sue E De Bono; Katrina L Lewis
Journal:  Med J Aust       Date:  2010-09-06       Impact factor: 7.738

7.  The symptom burden of patients with hematological malignancy: a cross-sectional observational study.

Authors:  Vanessa Manitta; Rachel Zordan; Merrole Cole-Sinclair; Harshal Nandurkar; Jennifer Philip
Journal:  J Pain Symptom Manage       Date:  2011-04-07       Impact factor: 3.612

Review 8.  Psychological distress: concept analysis.

Authors:  Sheila H Ridner
Journal:  J Adv Nurs       Date:  2004-03       Impact factor: 3.187

9.  Cutting the research pie: a value-weighting approach to explore perceptions about psychosocial research priorities for adults with haematological cancers.

Authors:  C L Paul; R Sanson-Fisher; H E Douglas; T Clinton-McHarg; A Williamson; D Barker
Journal:  Eur J Cancer Care (Engl)       Date:  2011-05       Impact factor: 2.520

10.  High levels of untreated distress and fatigue in cancer patients.

Authors:  L E Carlson; M Angen; J Cullum; E Goodey; J Koopmans; L Lamont; J H MacRae; M Martin; G Pelletier; J Robinson; J S A Simpson; M Speca; L Tillotson; B D Bultz
Journal:  Br J Cancer       Date:  2004-06-14       Impact factor: 7.640

View more
  7 in total

1.  The influence of unmet supportive care needs on anxiety and depression during cancer treatment and beyond: a longitudinal study of survivors of haematological cancers.

Authors:  Devesh Oberoi; Victoria M White; John F Seymour; H Miles Prince; Simon Harrison; Michael Jefford; Ingrid Winship; David Hill; Damien Bolton; Anne Kay; Jeremy Millar; Nicole Wong Doo; Graham Giles
Journal:  Support Care Cancer       Date:  2017-06-30       Impact factor: 3.603

2.  Management of febrile neutropenia in a patient with acute leukemia.

Authors:  Ashley Leak Bryant; AnnMarie Walton; Tara A Albrecht
Journal:  J Emerg Nurs       Date:  2013-09-17       Impact factor: 1.836

3.  Distress in patients with acute leukemia: a concept analysis.

Authors:  Tara A Albrecht; Margaret Rosenzweig
Journal:  Cancer Nurs       Date:  2014 May-Jun       Impact factor: 2.592

4.  Gentle Massage Improves Disease- and Treatment-Related Symptoms in Patients with Acute Myelogenous Leukemia.

Authors:  Ann Gill Taylor; Audrey E Snyder; Joel G Anderson; Cynthia J Brown; John J Densmore; Cheryl Bourguignon
Journal:  J Clin Trials       Date:  2014

5.  Who Needs What? Perceptions of Patients and Caregivers in Oncology Phase 1 Trials.

Authors:  Victoria Rezash; Janice Reed; Barbara Gedeon; Eric Parsons; Sandra Siedlecki; Bradley Daniels; Dale R Shepard
Journal:  J Patient Exp       Date:  2019-02-19

6.  The Mediating Role of Mental Adjustment in the Relationship between Perceived Stress and Depressive Symptoms in Hematological Cancer Patients: A Cross-Sectional Study.

Authors:  Yingchun Li; Ying Yang; Rong Zhang; Kun Yao; Zhuogang Liu
Journal:  PLoS One       Date:  2015-11-20       Impact factor: 3.240

7.  Internet-based grief therapy for bereaved individuals after loss due to Haematological cancer: study protocol of a randomized controlled trial.

Authors:  Rahel Hoffmann; Julia Große; Michaela Nagl; Dietger Niederwieser; Anja Mehnert; Anette Kersting
Journal:  BMC Psychiatry       Date:  2018-02-27       Impact factor: 3.630

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.